Published research, including studies referenced in NIH literature, shows associations between berberine and glucose management support, GLP-1 pathway activity in animal and some human models, and reductions in fasting glucose readings in controlled research settings
Usually, when people eat, it triggers the release of GLP-1
That distinction is what determines action
Heart and kidney protection While clinical trials have yet to study the long-term benefits of Soliqua and Xultophy, research suggests that GLP-1s on their own can help protect the heart and kidneys
Notably, the study applied strict exclusion criteria, thereby eliminating participants with pre-existing conditions or symptoms frequently associated with IR [111]
We understand the complexities of body mass and weight loss, and we do not determine eligibility solely based on the number on the scale